Cassava Sciences

+$11.97 (+17.22%) As of 6:38 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.

About SAVA

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.

CEO
Remi Barbier
Employees
11
Headquarters
Austin, Texas
Founded
1998

SAVA Key Statistics

Market Cap
3.26B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
8.79M
High Today
$87.00
Low Today
$75.00
Open Price
$77.20
Volume
11.92M
52 Week High
$146.16
52 Week Low
$2.78

SAVA News

Benzinga5h

A Forgettable Week For Alzheimer's Treatment Stocks: Two Of Our Top Names Come Back To Earth. This Is Why We Hedge.

Screen capture via Cassava Sciences' video for their Simufilam Alzheimer's disease treatment. Two Alzheimer's Names Come Back To Earth In a post last week (An

SAVA Earnings

-$0.09
-$0.06
-$0.03
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 16, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure